| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.86B | 74.48B | 71.85B | 61.56B | 58.80B | 54.34B |
| Gross Profit | 39.97B | 39.16B | 38.60B | 30.14B | 29.83B | 26.76B |
| EBITDA | 32.07B | 30.31B | 31.60B | 23.94B | 23.23B | 20.79B |
| Net Income | 18.62B | 18.16B | 19.24B | 15.22B | 15.02B | 13.35B |
Balance Sheet | ||||||
| Total Assets | 141.28B | 162.69B | 142.28B | 122.52B | 108.03B | 95.90B |
| Cash, Cash Equivalents and Short-Term Investments | 69.69B | 67.19B | 71.79B | 55.25B | 49.80B | 44.62B |
| Total Debt | 0.00 | 0.00 | 0.00 | 400.00M | 733.00M | 1.70B |
| Total Liabilities | 9.81B | 15.43B | 14.43B | 13.31B | 13.81B | 16.22B |
| Stockholders Equity | 131.47B | 147.26B | 127.85B | 109.20B | 94.22B | 79.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.54B | 15.37B | 5.97B | 6.95B | 11.02B |
| Operating Cash Flow | 0.00 | 16.93B | 25.35B | 17.22B | 15.65B | 14.76B |
| Investing Cash Flow | 0.00 | -21.76B | -7.68B | -10.81B | -8.76B | -3.52B |
| Financing Cash Flow | 0.00 | -1.22B | -1.51B | -1.36B | -1.88B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥814.20B | 20.33 | 8.07% | 2.85% | 11.53% | 1.60% | |
77 Outperform | ¥939.76B | 35.87 | 13.15% | 0.23% | 3.66% | -5.60% | |
72 Outperform | ¥14.90T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
67 Neutral | ¥6.88T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
63 Neutral | ¥1.44T | 53.01 | ― | 2.57% | 4.07% | 533.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥169.39B | 15.01 | 5.91% | 2.39% | 2.81% | -39.05% |